Volume 66, Number 17, 764-767, DOI: 10.1007/BF01726574

Evaluation of the clonidine-suppression test in the diagnosis of pheochromocytoma

G. Plewe, U. Krause, U. Cordes and J. Beyer

View Related Documents

Abstract

In this study we examined the preoperative value of the clonidine-suppression test in 15 patients with surgically proved pheochromocytomas. The result of the clonidine-suppression test was pathological (epinephrine plus norepinephrine above 500 ng/l 3 h after clonidine) in 10 of 15 patients (66%). These patients had relatively large tumors and higher basal norepinephrine plasma levels. Out of the 5 cases without a pathological clonidine test 4 had normal basal plasma catecholamine levels with the result that the clonidine test could not be properly applied and 1 case produced a false negative result. These 5 cases generally had smaller tumors and lower plasma catecholamine levels. Two of these cases had basally raised epinephrine values. The other three cases had either a paradoxical increase or a suspiciously low fall (less than 25%) in norepinephrine within the normal range. We conclude that the clonidine-suppression test is only reliable for the diagnosis of relatively large pheochromocytomas.

Key words  Catecholamines - Clonidine - Pheochromocytoma

Fulltext Preview

Image of the first page of the fulltext document